基于脑转移瘤MR序列的影像组学特征鉴别EGFR与ALK突变状态
本研究回顾性纳入186例肺癌脑转移患者,从T1-CE、T2-FLAIR和T2WI序列提取影像组学特征并构建随机森林模型,用于鉴别EGFR突变与ALK重排。T2-FLAIR模型在训练集和测试集的AUC分别为0.991和0.950,显著高于T1-CE和T2WI模型。T2-FLAIR和T1-CE影像组学模型可作为无创工具帮助指导治疗策略。
要点
- T2-FLAIR影像组学模型鉴别EGFR与ALK突变的AUC最高,训练集0.991、测试集0.950。
- T1-CE模型F1分数略高于T2-FLAIR,但AUC较低。
- T2WI模型鉴别能力最差,测试集AUC仅0.731。
核心结论
- 基于T2-FLAIR和T1-CE的影像组学模型可作为无创工具鉴别脑转移瘤的EGFR突变与ALK重排状态,有助于指导治疗策略。
研究设计与样本
- 从T1-CE、T2-FLAIR和T2WI三个MR序列分别提取影像组学特征,采用随机森林分类器构建模型,以ROC曲线在训练集和测试集验证模型能力。
诊断标准与关键数值
- T2-FLAIR模型AUC在训练集为0.991、测试集为0.950,均显著高于T1-CE模型(训练集0.954、测试集0.867)和T2WI模型(训练集0.880、测试集0.731)。
- T1-CE模型F1分数略高于T2-FLAIR模型,且远高于T2WI模型(两个队列中均如此)。
临床应用与阅片要点
- 阅片时可优先关注T2-FLAIR序列提取的影像组学特征用于无创预测EGFR/ALK突变状态。
- T1-CE模型F1分数略高,提示其在阳性预测值方面可能有一定优势,但原文未进一步说明。
局限性
- 本研究为回顾性设计,样本量有限(共186例),未报告多中心外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: More and more small brain metastases (BMs) in asymptomatic patients can be detected even prior to their primary lung cancer with the development of MRI. The aim of this study was to develop a predictive radiomics model to identify epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutation status in BM and explore the optimal MR sequence for predication.
METHODS: This retrospective study included 186 patients with proven BM of lung cancer (training cohort: 70 patients with EGFR mutations and 65 patients with ALK rearrangements; testing cohort: 26 patients with EGFR mutations and 25 patients with ALK rearrangements). Radiomics features were separately extracted from contrast-enhanced T1-weighted imaging (T1-CE), T2 fluid-attenuated inversion recovery (T2-FLAIR) and T2WI sequences. The model for three MR sequences were constructed using a random forest classifier. ROC curves were used to validate the capability of the models in the training and testing cohorts.
RESULTS: The AUCs of the T2-FLAIR model were significantly higher than those of the T1-CE model in training cohort (0.991 versus 0.954) and testing cohort (0.950 versus 0.867) and much higher than those of the T2WI model in training cohort (0.991 versus 0.880) and testing cohort (0.950 versus 0.731). Besides, the F1 scores of the T1-CE model were slightly higher than the T2-FLAIR model and much higher than the T2WI model in two cohorts.
CONCLUSION: T2-FLAIR and T1-CE radiomics models that can be used as noninvasive tools for identifying EGFR and ALK mutation status are helpful to guide therapeutic strategies.
引用
- Li, Lv, Wang, et al. Differentiating EGFR from ALK mutation status using radiomics signature based on MR sequences of brain metastasis. Eur J Radiol. 2022. PMID: 36049410. doi:10.1016/j.ejrad.2022.110499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。